Groowe Groowe / Newsroom / CELU
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CELU News

Celularity Inc. Class A Common Stock

Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease

globenewswire.com
CELU